BIOCRYST PHARMS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 175 filers reported holding BIOCRYST PHARMS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,633 | -51.3% | 469,430 | -58.5% | 0.19% | -41.3% |
| Q4 2021 | $15,659 | +25.6% | 1,130,578 | +30.3% | 0.32% | +35.9% |
| Q3 2021 | $12,472 | +73.8% | 867,920 | +91.2% | 0.24% | +76.9% |
| Q2 2021 | $7,178 | +64.2% | 453,995 | +5.6% | 0.13% | +44.1% |
| Q1 2021 | $4,372 | – | 429,902 | – | 0.09% | – |
Download | ||||||